How one lab stopped chasing its own data.

How an India-based CRDMO Unified 6,000+ Scientists with One Digital Platform

India’s biotechnology sector is expanding at an unprecedented pace, with CRDMOs playing a vital role in supporting pharma and biotech innovation worldwide. Yet rapid growth brings operational challenges: fragmented systems, compliance pressures, and the rising complexity of interdisciplinary science. This case study highlights how one of India’s largest CRDMOs partnered with Dotmatics to unify its data environment, streamline scientific workflows, and empower 2,000+ researchers in the initial rollout—with plans to scale to over 6,000.

 
3 Takeaways
 

• Unified Data Management: Dotmatics integrated chemical and biological domains into a single ELN, centralizing registration and inventory for full compliance and traceability.

• Seamless Tool Integration: Native connectivity with SnapGene, Geneious, and GraphPad Prism enabled researchers to work in their preferred applications while maintaining data continuity.

• Scalable Future-Readiness: A flexible licensing model and plans to extend into Dotmatics Luma and Lab Connect position the CRDMO for long-term growth in India’s fast-expanding biotech landscape.

This deployment marks a milestone in scientific digitalization for India’s life sciences ecosystem. By adopting Dotmatics, the CRDMO not only solved immediate challenges of fragmented workflows and compliance but also laid a foundation for scalable, AI-ready innovation. For India’s biotech industry, this case study demonstrates how unified platforms can accelerate collaboration, reduce costs, and keep pace with global research demands.

Discover how your organization can overcome data silos and scale scientific innovation.